Obesity is not only a lifestyle issue but a major risk factor for cancer in men. With rising obesity rates in India, it’s ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

In that light, the GLP-1 rebound effect is not an obstacle but an opportunity to chart a new, holistic course in obesity care ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Semaglutides, which are used to treat type 2 diabetes and obesity, were the most-sold medication in Finland last year, ...

Global Liver Institute Calls for Urgent Action as Fatty Liver Disease Prevalence Surges Worldwide Today is Global Fatty Liver ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.

Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said ...

A large European study found that consuming a greater variety of plant-based proteins, vegetables, and major food groups is linked to a lower risk of developing type 2 diabetes. The protective effect ...